Jürgen Becker

A prospective, randomized pilot study on the safety and efficacy of recombinant human growth and differentiation factor-5 coated onto β-tricalcium phosphate for sinus lift augmentation.

H. Terheyden, F. Koch, W. Wagner, 2010, Clinical oral implants research.

Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein 2 (rhBMP-2). A pilot study in dogs

H. Jennissen, M. Chatzinikolaidou, F. Schwarz, 2006, Clinical Oral Investigations.

Histological evaluation of maxillary sinus floor augmentation with recombinant human growth and differentiation factor-5-coated β-tricalcium phosphate: results of a multicenter randomized clinical trial.

Y. Açil, H. Terheyden, A. Stavropoulos, 2011, Journal of clinical periodontology.